Impairment of endogenous melatonin rhythm is related to the degree of chronic kidney disease (CREAM study)

Nephrology Dialysis Transplantation

Volumn 25, Issue 2, 2010, Pages 513-519

  Koch, Birgit C P ^a   Van Der Putten, Karien ^a   Van Someren, Eus J W ^b,c   Wielders, Jos P M ^a   Ter Wee, Piet M ^c   Nagtegaal, J Elsbeth ^a   Gaillard, Carlo A J M ^a  

^a Meander MC ^*  (Netherlands)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chronic kidney disease; Circadian rhythm; Core body temperature; Cortisol; Melatonin

Indexed keywords

HYDROCORTISONE; MELATONIN;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CORE TEMPERATURE; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL;

AGED; BODY TEMPERATURE; CHRONIC DISEASE; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYDROCORTISONE; KIDNEY; KIDNEY DISEASES; MALE; MELATONIN;

EID: 75649091144     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp493     Document Type: Article

References (49)

1. De Santo RM, Bartiromo M, Cesare MC et al. Sleeping disorders in early chronic kidney disease. Semin Nephrol 2006; 26: 64-67
2. Parker KP. Sleep disturbances in dialysis patients. Sleep Med Rev 2003; 7: 131-143
3. Minors DS, Waterhouse JM. Circadian rhythms and their mechanisms. Experientia 1986; 42: 1-13
4. Koopman MG, Koomen GC, Krediet RT et al. Circadian rhythm of glomerular filtration rate in normal individuals. Clin Sci (Lond) 1989; 77: 105-111
5. Vaziri ND, Oveisi F, Reyes GA et al. Dysregulation of melatonin metabolism in chronic renal insufficiency: role of erythropoietin-deficiency anemia. Kidney Int 1996; 50: 653-656
6. Farmer CK, Goldsmith DJ, Cox J et al. An investigation of the effect of advancing uraemia, renal replacement therapy and after renal transplantation on blood pressure diurnal variability. Nephrol Dial Transplant 1997; 12: 2301-2307
7. Claustrat B, Brun J, Chazot G. The basic physiology and pathophysi-ology of melatonin. Sleep Med Rev 2005; 9:11-24.
8. Lewy AJ, Sack RL. The dim light melatonin onset as a marker for circadian phase position. Chronobiol Int 1989; 6: 93-102
9. Tzischinsky O, Shlitner A, Lavie Pl. The association between the nocturnal sleep gate and nocturnal onset of urinary 6-sulfatoxymelatonin. J Biol Rhythms 1993; 8: 199-209
10. Van Der Helm-Van Mil AHM, Van Someren EJW, Van Den Boom R et al. No influence of melatonin on cerebral blood flow in humans. J Clin Endocrinol Metab 2003; 88: 5989-5994.
11. Van Someren EJW. Sleep propensity is modulated by circadian and behavior-induced changes in cutaneous temperature. J Therm Biol 2004; 29: 437-444
12. Torres-Farfan C, Richter HG, Rojas-Garćia P et al. Mt1 melatonin receptor in the primate adrenal gland: inhibition of adrenocorticotropin- stimulated cortisol production by melatonin. J Clin Endocrinol Metab 2003; 88: 450-458
13. Koch BC, Hagen EC, Nagtegaal JE et al. Effects of nocturnal hemodialysis on melatonin rhythm and sleep-wake behavior: an uncontrolled trial. Am J Kidney Dis 2009: 53: 658-664
14. Karasek M, Szuflet A, Chrzanowski W et al. Decreased melatonin nocturnal concentrations in hemodialyzed patients. Neuro Endocrinol Lett 2005; 26: 653-656
15. Koch BC, Nagtegaal JE, Hagen EC et al. The effects of melatonin on sleep-wake rhythm of daytime haemodialysis patients: a randomized, placebo-controlled, cross-over study (EMSCAP study). Br J Clin Pharmacol 2009; 67: 68-75
16. Nagtegaal JE, Kerkhof GA, Smits MG et al. Delayed sleep phase syndrome: a placebo-controlled cross-over study on the effects of melatonin administered five hours before the individual dim light melatonin onset. J Sleep Res 1998; 7: 135-143
17. McKenzie JE, Osgood DW. Validation of a new telemetric core temperature monitor. J Therm Biol 2004; 29: 605-611
18. Van Someren EJ, Nagtegaal E. Improving melatonin circadian phase estimates. Sleep Med 2007; 6: 590-601
19. Ruf T. The baseline cosinus function: a periodic regression model for biological rhythms. Biol Rhythm Res 1996; 27: 153-165
20. Batschelet E (ed). Circular Statistics in Biology. London: Academic Press, 1981
21. Bardsley WG, Bukhari NAJ, Ferguson MWJet al.Evaluationofmodel discrimination, parameter estimation and goodness of fit in nonlinear regression problems by test statistics distributions. Comput Chem 1995; 19: 75-84
22. Poeggeler B, Reiter RJ, Tan DX et al. Melatonin, hydroxyl radical-mediated oxidative damage, and aging: a hypothesis. J Pineal Res 1993; 14: 151-168
23. Reiter RJ. Melatonin: clinical relevance. Best Pract Res Clin En-docrinol Metab 2003; 17: 273-285
24. Geron R, Shurtz-Swirski R, Sela S et al. Polymorphonuclear leucocyte primingin long intermittent nocturnal haemodialysis patients-is melatonin a player? Nephrol Dial Transplant 2006; 21: 3196-3201
25. Markus RP, Ferreira ZS, Fernandes PA et al. The immune-pineal axis: a shuttle between endocrine and paracrine melatonin sources. Neuroimmunomodulation 2007; 14, 126-133
26. Scheer FA, Van Montfrans GA, van Someren EJ et al. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 2004; 43: 192-197
27. Souchet T, Brée F, Baatard R et al. Impaired regulation of beta 2-adrenergic receptor density in mononuclear cells during chronic renal failure. Biochem Pharmacol 1986; 35: 2513-2519
28. Nagtegaal JE, Smits MG, Kerkhof GA et al. Chronobiological, clinical and pharmacological aspects of melatonin in human circadian rhythm dysfunction. In: Haldar C, Singaravel M, Kumar Maitra S (eds). Treatise on Pineal Gland and Melatonin. Enfield, UK: Science Publishers, 2002, 461-489
29. Holmes EW, Hojvat SA, Kahn SE et al. Testicular dysfunction in experimental chronic renal insufficiency: a deficiency of nocturnal pineal N-acetyltransferase activity. Br J Exp Pathol 1989; 70: 349-356
30. Ulfberg J, Micic S, Strøm J. Afternoon serum-melatonin in sleep disordered breathing. J Intern Med 1998; 244: 163-168
31. Hanly P, Gabor JY, Chan C et al. Daytime sleepiness in patients with CRF: impact of nocturnal hemodialysis. Am J Kidney Dis 2003; 41: 403-410
32. Benz RL, Pressman MR, Hovick ET et al. A preliminary study of the effects of correction of anemia with recombinant human erythro-poietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study). Am J Kidney Dis 1999; 34: 1089-1095
33. Van Der Putten K, Koch BC, Van Someren EJW et al. Circadian rhythm of erythropoietin and IGF-1 in Chronic Kidney Disease (CREAM study). submitted
34. Van Someren EJW. Mechanisms and functions of coupling between sleep and temperature rhythms. Prog Brain Res 2006; 153: 309-324
35. Lack LC, Gradisar M, Van Someren EJ et al. The relationship between insomnia and body temperatures. Sleep Med Rev 2008; 12: 307-317
36. Robles NR, Alvarez-Lobato VC, Caravaca F et al. Sympathetic skin response in peritoneal dialysis patients. ASAIO J 2003; 49: 88-90
37. Van Ree RM, Oterdoom LH, de Vries AP et al. Circulating markers of endothelial dysfunction interact with proteinuria in predicting mortality in renal transplant recipients. Transplantation 2008; 86: 1713-1719
38. Petrofsky JS, McLellan K, Bains GS et al. Skin Heat Dissipation: the influence of diabetes, skin thickness, and subcutaneous fat thickness. Diabetes Technol Ther 2008; 10: 487-494
39. Parker KP, Bailey JL, Rye DB et al. Lowering dialysate temperature improves sleep and alters nocturnal skin temperature in patients on chronic hemodialysis. J Sleep Res 2007; 16: 42-50
40. Hathaway DK, Cashion AK, Milstead EJ et al. Autonomic dysregu-lation in patients awaiting kidney transplantation. Am J Kidney Dis 1998; 32: 221-229
41. Palmer BF. Metabolic disturbances in chronic renal failure. Saudi J Kidney Dis Transpl 2002; 13: 273-280
42. Nolan GE, Smith JB, Chavre VJ et al. Spurious overestimation of plasma cortisol in patients with chronic renal failure. Endocrinol Metab 1981; 48: 95-95
43. Rosman PM, Benn R, Kay M et al. Cortisol binding in uremic plasma. Absence of abnormal cortisol binding to cortico-binding globulin. Nephron 1984; 37: 160-165 (Pubitemid 14144217)
44. Betts PR, Howse PM, Morris R et al. Serum cortisol concentrations in children with chronic renal insufficiency. Arch Dis Child 1975; 50: 245-247
45. TaheriS.Sleep and metabolism: bringing piecesofthe jigsaw together. Sleep Med Rev 2007; 1: 159-162
46. Knutson KL, Steiger K, Penev P et al. The metabolic consequences of sleep deprivation. Sleep Med Rev 2007; 1: 163-178
47. Scheer FA, Van Paassen B, Van Montfrans GA et al. Human basal cortisol levels are increased in hospital compared to home setting. Neurosci Lett 2002; 333: 79-82
48. Vaughan GM. Melatonin in humans. Pineal Res Rev 1984; 2: 141-202
49. Werner S, Brismar K, Wetterberg L et al. Circadian rhythms of mela-tonin, prolactin, growth hormone, and cortisol in patients with pituitary adenomas, empty cell syndrome and Cushing syndrome due to adrenal tumors. Adv Biosci 1981; 29: 357-363